Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CICERO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.036
EU - Europa 5.340
AS - Asia 4.528
SA - Sud America 766
Continente sconosciuto - Info sul continente non disponibili 585
AF - Africa 126
OC - Oceania 28
Totale 24.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.772
SG - Singapore 1.509
RU - Federazione Russa 1.315
CN - Cina 1.240
IT - Italia 1.081
FI - Finlandia 689
BR - Brasile 579
DE - Germania 537
HK - Hong Kong 412
VN - Vietnam 410
GB - Regno Unito 330
UA - Ucraina 268
PL - Polonia 245
IE - Irlanda 219
FR - Francia 198
JP - Giappone 156
BD - Bangladesh 139
CA - Canada 131
SE - Svezia 127
KR - Corea 118
IN - India 117
TR - Turchia 69
AR - Argentina 65
IQ - Iraq 65
RO - Romania 54
BE - Belgio 53
NL - Olanda 50
ES - Italia 46
MX - Messico 42
ZA - Sudafrica 34
MY - Malesia 32
AT - Austria 31
CO - Colombia 31
PH - Filippine 28
UZ - Uzbekistan 28
EC - Ecuador 25
AU - Australia 24
CR - Costa Rica 24
VE - Venezuela 24
ID - Indonesia 22
IR - Iran 22
CI - Costa d'Avorio 19
CL - Cile 18
SA - Arabia Saudita 18
IL - Israele 16
MA - Marocco 16
NP - Nepal 16
PK - Pakistan 13
PY - Paraguay 13
CZ - Repubblica Ceca 12
JM - Giamaica 12
LT - Lituania 12
HN - Honduras 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
EE - Estonia 9
TN - Tunisia 9
TW - Taiwan 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
KE - Kenya 8
KZ - Kazakistan 8
NI - Nicaragua 8
DK - Danimarca 7
DZ - Algeria 7
EG - Egitto 7
SI - Slovenia 7
SV - El Salvador 7
GR - Grecia 6
KG - Kirghizistan 6
LB - Libano 6
PA - Panama 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
AZ - Azerbaigian 5
KW - Kuwait 5
NO - Norvegia 5
SC - Seychelles 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
EU - Europa 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
OM - Oman 4
SD - Sudan 4
TT - Trinidad e Tobago 4
NG - Nigeria 3
PE - Perù 3
PR - Porto Rico 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BJ - Benin 2
CM - Camerun 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
Totale 23.788
Salva come PNG Salva come JPEG
Città #
Ashburn 1.656
Fairfield 1.372
Singapore 1.002
San Jose 869
Woodbridge 745
Chandler 687
Houston 571
Seattle 564
Wilmington 553
Ann Arbor 524
Cambridge 479
Hong Kong 393
Council Bluffs 279
Palermo 268
Moscow 240
Dublin 212
Zgierz 209
Beijing 182
Santa Clara 181
Los Angeles 180
Medford 169
New York 166
Tokyo 148
Jacksonville 129
Boardman 125
Ho Chi Minh City 125
Hefei 119
Altamura 116
Dallas 115
Des Moines 114
Nanjing 108
Frankfurt am Main 107
Hanoi 102
Princeton 102
Helsinki 97
Lauterbourg 97
The Dalles 93
Lawrence 89
Chicago 88
San Diego 80
Dearborn 69
São Paulo 58
Buffalo 55
Changsha 54
Milan 54
Phoenix 53
Brussels 51
London 50
Tulsa 50
Shenyang 49
Rome 45
Orem 44
Ludwigshafen am Rhein 38
Nanchang 35
Nuremberg 35
Brooklyn 34
Toronto 34
Denver 33
Jinan 33
Hebei 32
Tianjin 32
Bremen 31
Seoul 31
Zhengzhou 30
Kumar 29
Jiaxing 28
Amsterdam 27
Atlanta 27
Montreal 27
Panama City 27
Guangzhou 26
Izmir 26
Chennai 25
Da Nang 24
Baghdad 23
Columbus 23
Munich 23
Redwood City 22
Ningbo 21
Stockholm 21
Falls Church 20
Rio de Janeiro 20
Warsaw 20
Berlin 19
Saint Petersburg 19
Tashkent 19
Abidjan 18
Haiphong 18
Seongnam 18
Shanghai 18
Springfield 18
Poplar 17
Boydton 16
Johannesburg 16
Hangzhou 15
Newark 15
San Francisco 15
Venice 15
Verona 15
Auburn Hills 14
Totale 15.229
Salva come PNG Salva come JPEG
Nome #
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 359
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 358
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 355
Psychological distress and quality of life in ostomy patients with colorectal cancer: A systematic review of the literature 345
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 328
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 324
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 324
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 322
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 319
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 316
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 314
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 312
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 312
A headlight on liquid biopsies: a challenging tool for breast cancer management 311
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 307
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 300
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 298
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 294
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 292
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 291
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 284
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 284
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 284
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 282
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 281
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 280
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 279
Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice 279
Monoclonal antibodies in gastrointestinal cancers 277
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 277
HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY 275
Targeted Therapies in Hepatocellular Carcinoma 272
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer 268
Circulating exosomal Hsp60 as a new marker of colon cancer. 263
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 263
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 262
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 261
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 261
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 259
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 257
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 252
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 250
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 248
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 243
Studio di fase II con Taxotere + Doxorubicina liposomiale + Trastuzumab nel trattamento del carcinoma mammario metastatico c-erb-B2 positivo 241
Primary Non-Hodgkin’s lymphoma of the parotid gland 237
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life 236
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 235
Well-being among Italian medical oncologists: An exploratory study 234
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy 232
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 230
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 229
The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patients and physician 228
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 224
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 223
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 222
Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis 220
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 219
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 217
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? 217
Bortezomib: a new pro-apoptotic agent in cancer treatment. 216
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 214
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer 213
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 209
Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an italian clinical axperience 203
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 202
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 201
The clinical efficacy of enzalutamide in metastatic prostate cancer: Prospective single-center study 201
The Role of Couples' Attachment Styles in Patients' Adjustment to Cancer 200
Cardiotossicità e Cardioprotezione. 197
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 196
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 196
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 195
Unusual case of dorsal vertebral metastases from a male breast cancer 195
Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica 194
Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? 194
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 192
Geldanamycin and its derivatives as Hsp90 inhibitors 188
Studio di fase II con Gemcitabine + Oxaliplatino in combinazione nel trattamento delle neoplasie delle vie biliari, pancreas e colecisti in fase metastatica. 187
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 187
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer 182
Role of densitometric criteria in evaluation of effectiveness of antiangiogenic therapies in metastatic colorectal cancer: An Italian clinical experience 179
Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 178
Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study 172
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 169
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience 168
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 167
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 163
Emergenze metaboliche 160
Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients 155
Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams 155
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 153
Ramucirumab and its use in gastric cancer treatment 151
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen 151
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY 145
Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life 143
Avelumab in First Line Maintenance in Advanced Urothelial Carcinoma (aUC) in Elderly Patients: Efficacy, Tolerability, and Quality of Life in Real Life Setting 138
NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study 132
Terapia medica e supporto psicologico in un gruppo di pazienti affette da carcinoma mammario 122
Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: A retrospective study 121
Totale 23.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.089 0 0 0 96 78 73 91 107 157 130 127 230
2022/20231.912 196 381 38 235 217 260 84 154 189 11 99 48
2023/2024885 32 107 60 67 57 162 78 111 7 28 40 136
2024/20252.267 49 175 233 171 103 87 151 185 133 253 282 445
2025/20267.704 612 242 405 653 715 1.164 1.011 825 525 881 316 355
2026/20271.918 369 258 997 294 0 0 0 0 0 0 0 0
Totale 24.409